exosom
natur
occur
extracellular
vesicl
releas
mammalian
cell
bodi
fluid
exosom
known
key
mediat
cellcel
commun
facilit
transfer
genet
biochem
inform
distant
cell
structur
exosom
compos
lipid
protein
also
sever
type
rna
enabl
vesicl
serv
import
diseas
biomark
moreov
exosom
emerg
novel
drug
gene
deliveri
tool
owe
multipl
advantag
convent
deliveri
system
recent
increas
attent
focus
exosom
deliveri
drug
includ
therapeut
recombin
protein
variou
target
tissu
exosom
also
promis
vehicl
deliveri
microrna
small
interf
rna
usual
hamper
rapid
degrad
rna
well
ineffici
tissu
specif
current
avail
deliveri
strategi
review
highlight
recent
accomplish
trend
use
exosom
deliveri
drug
therapeut
rna
molecul
k
e
w
r
drug
deliveri
exosom
mirna
sirna
vesicl
transform
membran
evid
lipid
contribut
creation
ilv
mvb
hand
escrt
involv
cargo
sort
batrakova
kim
moreov
plasma
membran
protein
cytoplasm
molecul
incorpor
exosom
biogenesi
mechan
fulli
understood
exosom
share
structur
element
irrespect
origin
cell
produc
molecul
specif
cellderiv
exosom
reflect
physiolog
state
cell
produc
schorey
bhatnagar
vlassov
et
al
nanocarri
also
confer
endocyt
pathway
protein
export
scission
limit
endosom
result
cell
type
specif
protein
enclos
membran
parent
cell
uniqu
properti
home
select
topolog
orient
green
langer
anderson
simpson
et
al
cell
typespecif
protein
determin
exosom
function
simpson
et
al
henc
transmembran
protein
lactadherin
lysosom
associ
membran
platelet
deriv
growth
factor
receptor
pdgfr
heat
shock
protein
annexin
common
exosom
util
target
gene
deliveri
associ
home
peptid
surfac
exosom
alvarezerv
et
al
vlassov
et
al
xitong
xiaorong
addit
exosom
specif
protein
distinguish
microvesicl
alix
tetraspanin
simpson
et
al
initi
exosom
thought
cellular
mechan
remov
unwant
compon
howev
exosom
consid
natur
carrier
mani
signal
molecul
thu
play
import
role
pathogenesi
mani
diseas
involv
immun
system
sepsi
cardiovascular
cancer
ogorevc
kraljigl
veran
furthermor
exosom
modifi
variant
use
vector
cancer
therapi
deliveri
drug
microrna
mirna
small
interf
rna
sirna
mitochondri
dna
genom
dna
recombin
protein
baniz
et
al
therefor
tumorassoci
exosom
may
repres
import
biolog
defens
regulatori
mechan
cancer
develop
progress
moreov
exosomemedi
deliveri
cellderiv
cargo
might
provid
tissuespecif
biomark
would
allow
diagnosi
cancer
growth
earli
stage
heart
diseas
pregnanc
infect
et
al
review
chosen
focu
differ
deliveri
approach
noncod
rna
therapeut
drug
use
exosom
rnaibas
therapi
perform
small
interf
rna
sirna
microrna
mirna
demonstr
one
import
strategi
targetspecif
gene
silenc
kooijman
vader
van
dommelen
van
soling
schiffel
howev
spite
major
advanc
field
rnai
clinic
trial
perform
poor
bioavail
rapid
hydrolysi
inabl
cross
biolog
barrier
bloodbrain
barrier
major
concern
success
clinic
applic
sirna
schorey
bhatnagar
investig
reveal
nake
sirna
natur
affin
gene
silenc
spleen
kidney
liver
convers
exosomeencapsul
sirna
affin
aforement
tissu
undergo
specif
uptak
ogorevc
et
al
requir
two
critic
step
effici
deliv
mirna
sirna
specif
tissu
maintain
express
capac
target
desir
tissu
subsequ
deliveri
across
cell
membran
alvarezerv
et
al
mani
sirna
mirna
deliveri
method
develop
base
viral
nonvir
vector
use
gene
deliveri
although
viral
deliveri
gener
lead
longterm
gene
silenc
target
tissu
safeti
viral
vector
still
matter
concern
viral
deliveri
inher
drawback
exampl
result
activ
complement
coagul
factor
blood
circul
moreov
virus
recogn
preexist
antibodi
blood
stream
also
safeti
issu
regard
dysregul
gene
express
desir
tissu
might
lead
malign
transform
sever
complic
thu
limit
applic
viral
vector
clinic
practic
green
et
al
hornung
et
al
nonvir
deliveri
system
involv
synthet
carrier
polyethyleneimmin
pei
nanoparticl
liposom
promis
altern
abil
encapsul
sirna
protect
degrad
bloodstream
facilit
cellular
uptak
howev
although
nonvir
deliveri
system
surpass
safeti
concern
compar
viral
vector
potenti
problem
relat
inadequ
transfect
effici
induct
proinflammatori
respons
apoptosi
vivo
green
et
al
hornung
et
al
kooijman
et
al
exosom
featur
common
liposom
includ
phospholipid
bilay
compos
biocompat
substanc
dang
xitong
establish
exosom
benefit
natur
vehicl
transfer
sirna
high
target
specif
lack
immunolog
reaction
nanocarri
also
properti
effici
uptak
host
cell
due
uniqu
composit
endogen
synthet
lipid
protein
rna
found
deliveri
system
kooijman
et
al
accord
report
exosomemedi
deliveri
system
well
toler
vitro
vivo
demonstr
mtt
cytotox
test
immunolog
assess
ogorevc
et
al
comparison
exist
gene
therapi
vehicl
repeat
administr
exosom
activ
host
immun
respons
hornung
et
al
henc
suggest
exosom
benefit
synthet
nanocarri
cellmedi
drug
deliveri
system
lack
limit
mani
studi
demonstr
exist
rna
mrna
mirna
exosom
deriv
differ
cell
type
transfer
mirna
cell
consequ
suppress
target
gene
adlakha
saini
kooijman
et
al
thu
exosom
advantag
nanos
cellbas
deliveri
system
consid
effect
vehicl
target
deliveri
endogen
exogen
payload
green
et
al
mirna
small
noncod
rna
control
specif
target
mrna
inhibit
gene
express
either
posttranscript
shahabipour
et
al
transcript
level
baniz
et
al
contrast
sirna
wellknown
sequenc
specif
use
regul
express
one
specif
gene
mirna
regul
function
sever
gene
relat
signal
pathway
even
multipl
crosstalk
signal
pathway
increas
potenti
offtarget
effect
adlakha
saini
kooijman
et
al
similar
limit
relat
deliveri
sirna
mirna
properti
requir
suitabl
deliveri
system
endogen
mirna
encapsul
exosom
protect
endonucleas
degrad
although
synthet
mirna
short
halflif
blood
stream
variou
chemic
modif
util
improv
load
exosom
dang
xitong
kooijman
et
al
zhang
wang
gemeinhart
consid
two
main
compon
rnainduc
silenc
complex
risc
suggest
exosom
site
mirna
accumul
possibl
gene
silenc
montecalvo
et
al
importantli
associ
mvb
may
involv
sort
mirna
exosom
gib
ciaudo
erhardt
voinnet
zhang
et
al
natur
occur
rna
carrier
secret
mani
tumor
cell
contain
mirna
facilit
cellcel
commun
carcinogenesi
environment
chemic
induct
process
lead
prolifer
neighbor
normal
cell
exosom
load
mirna
inhibitor
consid
effect
carrier
system
compar
convent
transfect
method
use
treat
diseas
wang
et
al
thu
suggest
exosom
use
natur
sourc
mrna
mirna
carrier
baniz
et
al
consequ
exogen
sirna
type
rnai
mirna
mimic
also
load
exosom
transfer
recipi
cell
dang
xitong
elandaloussi
et
al
therapeut
applic
exosom
use
either
unmodifi
engin
form
mu
et
al
unmodifi
exosom
deriv
variou
cell
type
exhibit
desir
therapeut
properti
variou
applic
zitvogel
et
al
although
exosom
may
gener
mani
cell
type
eg
bone
marrow
blood
monocyt
macrophag
chosen
deliveri
drug
short
nucleic
acid
immatur
dendrit
cell
provid
untap
sourc
exosom
devoid
tcell
activ
suitabl
sourc
vaccin
purpos
furthermor
exosom
deriv
endotheli
cell
provid
appropri
sourc
exosom
deliv
sirna
endotheli
cell
without
unnecessari
compon
nonendotheli
origin
deriv
exosom
differ
type
cell
may
confer
differ
composit
function
baniz
et
al
exosom
may
also
engin
incorpor
therapeut
cargo
protein
therapeut
rna
convent
lowmolecularweight
organ
drug
molecul
order
confer
desir
therapeut
activ
akao
et
al
mu
et
al
ogorevc
et
al
differ
strategi
employ
describ
exosomebas
deliveri
system
point
rna
therapi
exosom
load
therapeut
mirna
sirna
use
differ
method
electropor
repres
one
broadli
applic
method
introduc
exogen
rna
therapeut
molecul
onto
surfac
purifi
exosom
alvarezervitiz
other
success
util
electropor
introduc
sirna
dendrit
cell
dc
deriv
exosom
modifi
express
rabi
viru
glycoprotein
rvg
deriv
peptid
fuse
integr
exosom
membran
protein
trigger
neuron
cell
knock
express
desir
gene
vivo
alvarezerv
et
al
ogorevc
et
al
rvg
exosom
could
use
longterm
silenc
gene
relat
neurodegen
diseas
howev
electropor
may
effect
configur
rna
mirna
shrna
contain
numer
chemic
modif
dang
xitong
therefor
qualiti
exosom
prepar
electropor
depend
condit
use
exampl
buffer
resuspend
exosom
van
der
meel
et
al
electropor
protocol
use
load
sirna
exosom
reveal
conflict
result
report
hamper
neg
charg
sirna
thu
sirna
complex
within
cation
liposom
follow
fusion
exosom
may
overcom
mani
limit
associ
expuls
sirna
extracellular
vesicl
wang
et
al
moreov
slightli
elev
temperatur
may
improv
load
sirna
exosom
van
der
meel
et
al
anoth
way
incorpor
rna
exosom
overexpress
cargo
rna
exosomeproduc
cell
rna
mirna
modifi
mirna
shrna
complet
function
incub
recipi
cell
result
target
gene
knockdown
marcu
leonard
rechavi
et
al
cellpenetr
peptid
cppexosom
good
exampl
improv
overal
uptak
effici
exosom
cpp
exosom
short
cation
peptid
fuse
display
surfac
exosom
may
employ
appropri
cargo
enter
cell
shield
neg
charg
exosom
elandaloussi
holm
langel
anoth
strategi
introduc
mirna
exosom
transient
transfect
use
commerci
transfect
reagent
dang
xitong
shtam
et
al
exosom
display
technolog
anoth
method
introduc
exogen
sirna
success
differ
kind
human
exosom
wahlgren
et
al
use
exosom
potenti
therapeut
system
sever
issu
need
address
studi
shown
exosom
easili
clear
reticuluendotheli
system
re
sinc
mani
accumul
liver
hr
inject
mous
tail
vein
ohno
et
al
therefor
sever
strategi
develop
target
exosom
specif
cellular
receptor
one
approach
precis
deliveri
exosomemedi
cargo
specif
cell
type
har
virusderiv
protein
peptid
label
exosom
instanc
rvgexosom
display
central
nervou
systemspecif
rabi
viral
glycoprotein
abil
deliv
sirna
neural
cell
bind
acetylcholin
receptor
hand
untag
exosom
deliv
sirna
unintend
tissu
virusmodifi
exosom
repres
new
approach
specif
target
deliveri
mani
similar
virus
exosom
exosom
may
modifi
incorpor
viral
protein
may
exploit
specif
target
exosom
sun
et
al
viralinfect
cell
incorpor
viral
factor
like
virusencod
rna
exosom
could
effici
deliv
noninfect
target
cell
studi
reveal
enhanc
exosom
releas
infect
cell
rotaviru
noninfect
higher
tcell
inhibit
viral
product
detect
barreto
et
al
modifi
exosom
carri
viral
protein
incorpor
endogen
produc
exosom
increas
uptak
deliveri
exosom
desir
target
alvarezerv
et
al
kopperslal
hogenboom
middeldorp
pegtel
instanc
ebvinfect
b
cell
encod
bart
mirna
transfer
exosom
multipl
uninfect
recipi
cell
includ
monocytederiv
dc
ebvmirna
accumul
noninfect
recipi
cell
via
exosom
caus
suppress
ebv
target
gene
pegtel
et
al
likewis
plasma
exosom
deriv
peripher
blood
healthi
donor
abl
deliv
sirna
effect
target
cell
human
blood
mononuclear
cell
wahlgren
et
al
exosomemimet
repres
viabl
altern
method
deliv
mirna
sirna
directli
cytoplasm
target
cell
aim
biotechnolog
approach
synthet
exosom
less
complex
structur
har
crucial
compon
natur
exosom
requir
specif
effici
deliveri
exosom
target
tissu
sinc
liposom
spheric
lipid
bilay
structur
common
exosom
suggest
logic
base
creation
function
exosomemimet
recent
cellderiv
exosom
mimet
develop
util
cellular
membran
monocyt
macrophag
serial
extrud
filter
diminish
pore
size
manufactur
lipid
bilay
membran
vesicl
share
similar
properti
exosom
maintain
natur
target
capac
topolog
plasma
membran
protein
jang
gho
furthermor
exosomemimet
repres
excel
deliveri
system
avoid
nonimmunogen
nontox
deliveri
therapeut
cargo
sirna
mirna
desir
cell
kooijman
et
al
puri
et
al
addit
exosomemimet
promis
nanotechnolog
overcom
hurdl
exosom
purif
low
product
yield
jang
gho
gener
overal
effici
exosomemedi
deliveri
strategi
achiev
target
specif
recipi
cell
util
intracellular
mechan
intracellular
traffick
specif
mode
exosom
uptak
order
confer
best
deliveri
cargo
molecul
small
size
exosom
advantag
use
drug
deliveri
system
enabl
escap
rapid
clearanc
mononuclear
phagocyt
system
xitong
xiaorong
moreov
exosom
drug
deliveri
system
provid
uniqu
benefit
includ
stabil
blood
due
bypass
complement
system
effici
deliveri
drug
cytosol
target
cell
possibl
fewer
offtarget
effect
due
inher
biocompat
exosom
kooijman
et
al
exosom
cardiospher
deriv
cell
cdc
shown
produc
rang
differ
cardioprotect
effect
antiapoptot
antiinflammatori
antioxid
antifibrot
cardiomyogen
effect
jang
gho
pegtel
et
al
cdc
exosom
stimul
angiogenesi
induc
cardiomyocyt
prolifer
reduc
apoptosi
vitro
capac
exosom
regener
demonstr
chronic
myocardi
infarct
model
rat
attribut
reduct
collagen
deposit
induc
antifibrot
efficaci
via
paracrin
mechan
puri
et
al
xitong
xiaorong
exosom
deriv
endotheli
cell
suggest
promis
strategi
combat
atherosclerosi
sinc
atherosclerosi
fundament
caus
myocardi
infarct
stroke
system
administr
exosom
human
umbil
vein
endotheli
cell
huvec
reduc
atherosclerot
lesion
mice
fed
highfat
diet
huvec
exosom
found
enrich
multipl
mirna
result
control
target
gene
express
reduct
atherosclerot
lesion
mous
aorta
mu
et
al
addit
exosom
deriv
msc
reveal
druginduc
regener
cardioprotect
paracrin
effect
myocardi
reperfus
ischemia
injuri
liverdamag
mous
model
respect
ohno
et
al
rechavi
et
al
van
der
meel
et
al
hypoxia
induc
inflammatori
respons
lung
activ
macrophag
subsequ
elev
proinflammatori
mediat
may
caus
later
develop
hypox
pulmonari
hypertens
lee
et
al
pulmonari
hypertens
also
report
treat
applic
mscderiv
exosom
suppress
earli
inflamm
lung
induc
vascular
remodel
marcu
leonard
mesenchym
stromal
cell
exosom
tumor
antigen
could
stimul
cell
result
inhibit
tumor
growth
yu
finn
zitvogel
et
al
exampl
melanomaderiv
exosom
contain
immunogen
antigen
cea
expressd
releas
colon
carcinoma
cell
andr
et
al
phase
clinic
trial
evalu
effect
patientspecif
exosom
releas
dendrit
cell
load
tumor
antigen
peptid
dexosom
dex
melanoma
nonsmal
cell
lung
cancer
trial
demonstr
dexosom
immunotherapi
possibl
safe
involv
innat
adapt
immun
respons
result
stabil
diseas
increas
longterm
surviv
sever
patient
delcayr
le
pecq
viaud
et
al
ascit
deriv
exosom
colorect
cancer
patient
shown
safe
nontox
toler
use
cancer
vaccin
associ
gmcsf
effici
induc
potent
carcinoembryon
antigen
cea
specif
antitumor
immun
advanc
colorect
cancer
patient
dai
et
al
cancer
patient
advanc
diseas
tumorderiv
exosom
exert
effect
immun
stimulatori
antitumor
effect
despit
product
tumorderiv
exosom
zitvogel
et
al
tumorderiv
exosom
also
immunosuppress
follow
direct
administr
actual
result
enhanc
tumor
growth
delcayr
le
pecq
zitvogel
et
al
tumorderiv
exosom
shown
either
suppress
activ
effector
cell
target
myeloid
cell
modul
differenti
function
exampl
case
exosom
deriv
human
melanoma
colorect
carcinoma
cell
line
viaud
et
al
zitvogel
et
al
exosom
vaccin
also
explor
sarsassoci
coronaviru
infect
induc
atyp
pulmonari
diseas
fatal
kuat
cinatl
doerr
demonstr
exosom
contain
spike
protein
sarscov
induc
neutral
antibodi
titer
enhanc
prime
sarss
exosom
vaccin
boost
current
use
adenovir
vector
vaccin
exosom
may
also
candid
vaccin
allerg
diseas
exosom
like
vesicl
isol
bronchoalveolar
lavag
fluid
mice
respiratori
exposur
oliv
pollen
allergen
induc
toler
protect
allerg
sensit
mice
prado
et
al
exosom
consid
therapeut
tool
moder
neovascular
activ
neovascular
lead
increas
heal
wound
addit
reconstruct
hypox
injuri
prevent
neovascular
delay
tumor
develop
martinez
andriantsitohaina
exosom
secret
human
cell
angiogen
activ
isol
endotheli
cell
murin
model
vessel
growth
repres
signific
paracrin
effect
therapeut
angiogenesi
enhanc
recoveri
injuri
ischem
diseas
sahoo
et
al
autoimmun
diseas
exosom
may
also
use
treatment
autoimmun
diseas
anim
model
kim
et
al
show
administr
exosom
deriv
dc
express
abl
modifi
activ
apc
cell
vivo
fasl
fasdepend
mechan
result
effect
treatment
collageninduc
arthriti
suppress
delayedtyp
figur
schemat
represent
biogenesi
exosom
exosom
origin
endocyt
vesicl
invagin
cell
membran
result
format
earli
exosom
subsequ
late
exosom
call
mvb
mvb
contain
ilv
form
bud
endosom
membran
call
exosom
mvb
fuse
plasma
membran
give
rise
releas
exosom
extracellular
space
endosom
protein
alix
may
incorpor
exosom
assembl
facilit
process
b
two
import
compon
rnainduc
silenc
complex
risc
associ
mvb
mediat
mirna
sort
exosom
c
subsequ
fusion
cellderiv
exosom
plasma
membran
tetraspanin
interact
surfac
glycoprotein
target
cell
give
rise
cytosol
deliveri
sirna
directli
process
involv
creation
temporari
rnai
exosom
origin
inward
bud
lumen
mvb
cytoplasm
content
cell
origin
also
viral
compon
includ
mrna
small
noncod
rna
viral
glycoprotein
incorpor
exosom
releas
select
cargo
viralinfect
cell
virusmodifi
exosom
display
origin
surfac
marker
cell
membran
parent
cell
e
bioengin
virusmodifi
exosom
design
express
select
set
protein
small
noncod
rna
target
specif
receptor
exosom
fuse
endosom
membran
releas
noncod
rna
cytoplasm
load
sirna
rnai
risc
complex
target
cell
order
prevent
mrna
translat
protein
acronym
risc
rnainduc
silenc
complex
rnai
rna
interfer
sirna
small
interfer
rna
mvb
multivesicular
bodi
shahabipour
et
al
hypersensit
inflammatori
respons
also
vaccin
mice
exosom
fasl
indoleamin
dc
decreas
clinic
develop
mice
rheumatoid
arthriti
kim
et
al
kim
et
al
kim
kim
oligino
robbin
et
al
yin
ouyang
li
xiao
yang
exosom
dc
decreas
diseas
activ
occurr
intestin
bleed
murin
model
inflammatori
bowel
diseas
ibd
cai
et
al
yin
et
al
exosom
abl
carri
suffici
amount
therapeut
cargo
qualifi
drug
deliveri
vehicl
varieti
cargo
exhibit
desir
therapeut
effect
exosomebas
deliveri
particular
tissu
johnsen
et
al
exosom
also
known
natur
way
deliv
variou
larges
protein
exampl
catalas
incorpor
nanobas
polym
order
preserv
therapeut
protein
degrad
host
cell
improv
load
capac
subsequ
load
exosom
haney
et
al
differ
strategi
consid
attempt
load
protein
biomolecul
exosom
includ
incub
room
temperatur
exposur
freezethaw
cycl
permeabil
saponin
sonic
extrus
kuat
et
al
prado
et
al
singh
et
al
murin
mscsecret
exosom
load
paclitaxel
ptx
incub
parent
cell
drug
result
show
signific
amount
ptx
load
exosom
demonstr
hplc
beauvillain
et
al
similar
result
report
cell
incub
differ
anticanc
agent
ptx
etoposid
carboplatin
irinotecan
epirubicin
mitoxantron
result
antiprolif
activ
lv
et
al
summar
exosom
natur
occur
nanovesicular
structur
secret
almost
cell
type
bodi
fluid
function
cellcel
commun
distant
neighbor
cell
caus
research
util
exosom
next
gener
carrier
gene
therapi
moreov
exosom
mani
advantag
compar
exist
deliveri
system
includ
fact
nanos
vesicl
exhibit
permeabl
biolog
membran
limit
safeti
concern
well
immunolog
inert
nonmutagenesi
immunomodulatori
regen
properti
protein
orient
similar
origin
cell
deriv
compos
lipid
protein
also
nucleic
acid
especi
variou
rna
make
exosom
suitabl
potenti
carrier
exogen
cargo
includ
rnai
therapeut
compound
fig
mani
obstacl
associ
rnai
mirna
sirna
deliveri
vivo
overcom
exosomemedi
deliveri
system
furthermor
exosom
capabl
deliv
exogen
therapeut
agent
specif
tissu
alvarez
other
demonstr
success
target
rvgexosom
deliveri
brain
exosom
consid
promis
strategi
effect
safe
drug
deliveri
target
cell
acceler
progress
toward
routin
use
exosom
gene
deliveri
sever
issu
need
address
exampl
new
improv
technolog
critic
need
effici
load
therapeut
agent
exosom
addit
obtain
highli
purifi
exosom
larg
quantiti
still
requir
investig
inde
effici
safeti
featur
exosomebas
drug
formul
must
rigor
compar
exist
gene
deliveri
system
maxim
exploit
approach
treat
lifethreaten
diseas
conclus
continu
technolog
advanc
exosomemedi
deliveri
drug
gene
biotherapeut
transit
bench
research
clinic
set
author
disclosur
conflict
interest
report
beauvillain
c
just
dion
pierr
j
dimierpoisson
exosom
effect
vaccin
congenit
toxoplasmosi
mice
vaccin
beauvillain
c
ruiz
guiton
r
bout
dimierpoisson
vaccin
base
exosom
secret
dendrit
cell
line
confer
protect
gondii
infect
syngen
allogen
mice
microb
infect
cai
z
zhang
w
yang
f
yu
l
yu
z
pan
j
wang
j
immunosuppress
exosom
genemodifi
dendrit
cell
attenu
inflammatori
autoimmun
diseas
induc
regulatori
cell
cell
research
colino
j
snapper
c
exosom
bone
marrow
dendrit
cell
puls
diphtheria
toxoid
preferenti
induc
type
antigenspecif
igg
respons
naiv
recipi
absenc
free
antigen
journal
immunolog
dai
wei
wu
z
zhou
x
wei
x
huang
h
li
g
phase
clinic
trial
autolog
ascitesderiv
exosom
combin
gmcsf
colorect
cancer
molecular
therapi
